Business Wire

Mars and Cargill Deepen Renewable Energy Partnership With Innovative 224MWac Solar Procurement With GoldenPeaks Capital in Poland

7.10.2025 07:05:00 EEST | Business Wire | Press release

Share

Two leading global food companies, Mars and Cargill, announced they are spurring the development of more than 224MWac* of new renewable energy capacity through five virtual power purchase agreements (PPAs) in Poland. The PPAs were signed with GoldenPeaks Capital, one of Europe’s fastest-growing independent producers of renewable energy.

This collaboration builds on Mars and Cargill’s existing work on renewable energy, and reflects an innovative approach to supplier-customer engagement on climate action. The companies signed what is believed to be the largest multi-buyer renewable energy agreement in Poland and the Central and Eastern Europe (CEE) region, which is Europe’s most carbon-intensive grid.

“These solar PPA agreements will create new solar projects that enable Mars to reduce and eliminate its current scope 2 electricity emissions in Poland and also a portion of our scope 3 emissions as part of our Renewable Acceleration program where Mars is driving progress on renewable electricity in our value chain,” said Kevin Rabinovitch, Global VP of Sustainability at Mars. “Having a supplier like Cargill also working directly on its electricity use complements our approach. In Poland, by aggregating with our supplier, we gained scale and delivered a huge win for both of our organizations as we join forces to advance our individual companies’ climate goals.”

GoldenPeaks Capital will develop the new solar projects, which are expected to come online in 2027 and generate enough clean energy to power an estimated 200,000 households every year. 3Degrees, a leading global climate solutions provider, facilitated the agreements on behalf of Mars and Cargill.

“We’re proud to collaborate with Mars on this unique partnership,” said Christina Yagjian, Senior Director, Global Renewable Energy at Cargill. “Beyond lowering procurement costs and reducing emissions, this work deepens our commercial relationship and shows how partnership across the value chain can drive meaningful climate action.”

This effort demonstrates how supplier-customer partnerships can drive emissions reductions at scale and accelerate progress toward shared climate goals – offering a replicable model for the broader food and agriculture sector.

Adriano Agosti, Founder and Chairman of GoldenPeaks Capital, said: “The PPA agreements with Mars and Cargill highlight our partnership-driven approach, delivering complex, high-value energy solutions, further driving decarbonisation across the region."

“We applaud Mars and Cargill’s leadership with the signing of these PPAs,” added Tyler Espinoza, Global Head of Power Markets at 3Degrees. “They are setting an excellent example of how companies and their suppliers can effectively collaborate to make forward progress in their collective decarbonisation goals. We need more organisations to follow in their footsteps and make similar moves to collaborate and accelerate meaningful climate action.”

*MWac (megawatts alternating current) measures the usable electricity delivered to the power grid.

About Cargill

Cargill is committed to providing food, ingredients, agricultural solutions, and industrial products to nourish the world in a safe, responsible, and sustainable way. Sitting at the heart of the supply chain, we partner with farmers and customers to source, make and deliver products that are vital for living.

Our approximately 160,000 employees innovate with purpose, providing customers with life’s essentials so businesses can grow, communities prosper, and consumers live well. With 160 years of experience as a family company, we look ahead while remaining true to our values. We put people first. We reach higher. We do the right thing—today and for generations to come. For more information, visit Cargill.com and our News Center.

About Mars, Incorporated

Mars, Incorporated is driven by the belief that the world we want tomorrow starts with how we do business today. As an approximately $55bn family-owned business, our diverse and expanding portfolio of leading pet care products and veterinary services support pets all around the world and our quality snacking and food products delight millions of people every day. We produce some of the world’s best-loved brands including ROYAL CANIN®, PEDIGREE®, WHISKAS®, CESAR®, DOVE®, EXTRA®, M&M’s®, SNICKERS® and BEN’S ORIGINAL™. Our international networks of pet hospitals, including BANFIELD™, BLUEPEARL™, VCA™ and ANICURA™ span preventive, general, specialty, and emergency veterinary care, and our global veterinary diagnostics business ANTECH® offers breakthrough capabilities in pet diagnostics. The Mars Five Principles—Quality, Responsibility, Mutuality, Efficiency and Freedom—inspire our 150,000 Associates to act every day to help create a better world for people, pets and the planet.

About GoldenPeaks Capital

GoldenPeaks Capital is a company specializing in the construction and operation of solar systems and one of the largest photovoltaic system owners in Poland and Hungary, with over 15 years of experience in structuring energy projects worldwide. In addition, GPC is a pioneer in the introduction of new technologies in Eastern Europe with various BESS + PV pilot projects in Poland and Hungary. GoldenPeaks Capital will further increase the pace of shaping the industry of renewable energies in Eastern Europe by applying the seamless integration of all sectors of GPC, such as project development & engineering, financing & structuring, supply chain management, construction & commissioning, asset operations, and commercial & energy sales among others, ensuring an invaluable alignment of methodologies, ethics and goals. GoldenPeaks Capital has been awarded for its green commitment, receiving the highest sustainability quality score (SQS1) from Moody's for their green bond framework.

About 3Degrees

3Degrees is a leading global climate solutions provider, pioneer of environmental markets, and Certified B Corporation with offices across North America, Europe, and Asia. Our work is driven by the need for urgent climate action and has been for nearly 20 years. We deliver a full suite of clean energy and decarbonization solutions to help global Fortune 500 companies, utilities, and other organizations achieve their climate goals and address emissions in the fight against climate change. The 3Degrees team brings a commitment to integrity and deep expertise in climate strategy and implementation across scopes 1, 2, and 3 emissions, including global environmental commodities, renewable energy and carbon project development, and supply chain decarbonization. We help develop and deploy impactful climate solutions that make good business sense and advance an equitable transition to a low-carbon future. Learn more at 3Degrees.com or follow us on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251006920124/en/

Contacts

Rachel Fagan, rfagan@3degrees.com, 512.791.2083

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Strongest Half-Year in Curatis’s History — Revenue up 51% and Significant Progress on Corticorelin (C-PTBE-01)21.9.2026 08:03:00 EEST | Press release

Curatis Holding AG (SIX:CURN, “Curatis”) reports net sales from goods and services of CHF 7.9m for the first half of 2026, up 51% (H1 2025: CHF 5.2m), with the loss for the period narrowing to CHF -0.4m (H1 2025: CHF -1.2m) and cash and cash equivalents rising to CHF 3.6m (31 December 2025: CHF 1.9m). Curatis also advanced its corticorelin (C-PTBE-01) program on multiple levels, including an exclusive Japan licence with Neupharma and continued manufacturing progress. Business development and finances Net sales from goods increased by 46% to CHF 7.4m (H1 2025: CHF 5.0m) and net sales from services rose to CHF 0.6m (H1 2025: CHF 0.2m). Growth was driven both by products marketed for some time and by products added to the distribution portfolio in 2025 and 2026. The gross contribution from goods and services rose by 32% to CHF 1.8m (H1 2025: CHF 1.3m); the combined cost base grew by only 9% against net sales growth of 51%, as personnel expenses rose 5% to CHF 1.3m (H1 2025: CHF 1.2m) and

Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies21.9.2026 08:00:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today begins trading as a constituent of the Swiss Market Index (SMI), Switzerland's leading blue chip equity benchmark comprising 20 of the country's largest and most liquid listed companies. Less than three years after its IPO on the SIX Swiss Exchange in March 2024, Galderma has established itself as one of Switzerland's leading listed companies. Its inclusion in the SMI reflects the company's strong growth, disciplined execution and increasing relevance in Swiss and international capital markets as it advances its ambition to become the world's leading dermatology powerhouse. Since its IPO, Galderma has continued to execute its growth-focused integrated dermatology strategy, delivering strong performance across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Net sales increased from 4.410 billion USD in 2024 to 5.207 billion USD in 2025, driven by science-led innovation, portfolio and geogr

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye